BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder

Urologia Internationalis

Volumn 65, Issue 2, 2000, Pages 100-105

  Casetta, Giovanni ^a,c   Gontero, P ^a   Zitella, A ^a   Pelucelli, G ^a   Formiconi, A ^a   Priolo, G ^b   Martinasso, G ^b   Mengozzi, G ^b   Aimo, G ^b   Viberti, L ^a   Tizzani, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Dipartimento Discipline Medico Chirurgiche   (Italy)

Author keywords

Bladder; BTA TRAK; NMP22; Transitional cell carcinoma; Urine cytology

Indexed keywords

TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

EID: 0033761875     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064848     Document Type: Article

References (18)

1. Superficial bladder cancer: Progression and recurrence
2. Bladder cancer: Early diagnosis and evaluation of biological potential. A review of newer methods
3. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa
4. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms
5. Diagnostic accuracy of urine cytology and deoxyribonucleic acid flow cytometry and cytology on bladder washings during follow-up for bladder tumors
6. Human bladder tumor antigen is a member of the RCA (regulators of complement activation) gene family
7. Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors
8. Bladder cancer-associated nuclear matrix proteins
9. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment
10. Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer
11. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder
12. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
13. The diagnostic value of urine versus bladder washing in patients with bladder cancer
14. Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of thebladder: Experience on 137 patients
15. Comparison of screening methods in the detection of bladder cancer
16. BTA stat and BTA TRAK: A comparative evaluation ofurine testing for the diagnosis of transitional cell carcinoma of the bladder
17. Evaluation ofurinary level of NMP22 as a diagnostic markerfor stage pTa-pT1 bladder cancer: Comparison with urinary cytology and BTA test